Once again, these green shoots and genuine leadership are emerging from Scotland.
The Council of the GPhC has approved new guidance for pharmacist prescribers to ensure that they provide safe and effective care when prescribing. The Guidance for pharmacist prescribers covers five key areas that pharmacist prescribers must consider in order to prescribe safely and effectively. These are: Taking responsibility for prescribing safely. Keeping up to date and prescribing within their level of competence. Working in partnership with other healthcare professionals and persons seeking care. Prescribing considerations and clinic judgement. Raising concerns.
In the second in a series of professional dilemmas that will follow a pharmacists new to working in general practice.
Pharmacists have had the opportunity to train as independent prescribers since 2006. Since then many pharmacists have achieved the qualification. This is the first in a series of professional dilemmas that will seek to understand how pharmacists would approach certain situations in relation to being an independent prescriber.
Pharmacists have had the opportunity to train as independent prescribers since 2006. Since then many pharmacists have achieved the qualification. This is the first in a series of professional dilemmas that will seek to understand how pharmacists would approach certain situations in relation to being an independent prescriber.
Like so many others recently I took the leap to the promised land of general practice. I have not really written about my experience of working in general practice largely because until now (2 years in) I had my head down finding my feet in this devilishly complex yet interesting role.
Make no mistake pharmacist independent prescribing can easily become a very risky and potentially dangerous activity if the level of competence of the prescriber is not sufficient.
Sam Falconer talks about community pharmacy prescribing in Scotland, the need for more funding and hope for the future
The MHRA has recalled three batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid. As a precautionary measure to protect public health, the Medicines and Healthcare products Regulatory Agency (MHRA) today recalled three batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid (NMBA). The affected […]
“A pharmacist independent prescriber is a practitioner who is responsible and accountable for the assessment of patients with diagnosed or undiagnosed conditions and for decisions about clinical the clinical management required, including prescribing”(1). Due to the breadth of the role of a pharmacist independent prescriber, it is important to define the limitations of the […]
